Learn about TECARTUS® (brexucabtagene autoleucel) a CAR T-cell therapy for R/R mantle cell lymphoma and acute lymphoblastic leukemia in adults. See Important Safety Information & …

Learn about who TECARTUS® (brexucabtagene autoleucel) is for, how it works, and important treatment considerations. See Important Safety Information & Warnings.

Learn about the TECARTUS® (brexucabtagene autoleucel) treatment process and who may be part of your treatment team. See Important Safety Information & Warnings.

Find TECARTUS® (brexucabtagene autoleucel) resources and support options for both patients and caregivers. See Important Safety Information & Warnings.

Discover how patients responded to TECARTUS® (brexucabtagene autoleucel) in clinical trials. See Important Safety Information & Warnings.

Read about possible side effects of TECARTUS® (brexucabtagene autoleucel) and how treatment teams, caregivers, and patients can manage side effects. See Important Safety …

watch out for symptoms of side effects throughout recovery—some side effects may be hard for the patient to notice themselves (see the Managing side effects page and Important Facts …

Tell any healthcare provider that sees you that you are being treated with YESCARTA® or TECARTUS®. SHOW THIS CARD if you go to the emergency room or see any physician.

Jan 1, 2010 · Get help talking to your oncologist about TECARTUS™, the first CAR T-cell therapy for adults living with certain types of mantle cell lymphoma. See Safety Info here.